Zimmer Biomet Holdings Inc. recently announced that Suketu “Suky” Upadhyay has been appointed to executive vice president and chief financial officer of the company as Daniel P. Florin will be retiring. These changes will be effective July 1.
Currently, Upadhyay serves as senior vice president of global financial operations of Bristol-Myers Squibb.
“I was attracted to Zimmer Biomet because of the company’s significant opportunity to leverage its differentiated ecosystem of customer-centric solutions to help accelerate growth and provide true value to customers and patients. I look forward to working with Bryan and the rest of the leadership team to strive to further enhance the company’s financial and operational performance, and position Zimmer Biomet for continued success,” Upadhyay said in a company press release.
Florin has been with the company for more than 12 years.
“It has been a privilege to be a part of the Zimmer Biomet family, and I am very proud of our achievements,” Florin said in the release.
“We are confident that Suky is the right person to be our next chief financial officer and look forward to his contributions as we continue to transition to offense and position ourselves to deliver significant value to shareholders,” Bryan Hanson, president and CEO of Zimmer Biomet, said in the release.